Psychological factors and stress in inflammatory bowel disease

References

• Schoultz M. The role of psychological factors in inflammatory bowel disease. Br. J. Community Nurs. 17(8), 370–374 (2012).
   PubMedGoogle Scholar
• Reber SO. Stress and animal models of inflammatory bowel disease – an update on the role of the hypothalamo–pituitary–adrenal axis. Psychoneuroendocrinology 37(1), 1–19 (2012).
   PubMed Web of Science ®Google Scholar
• Cantor DS. Crohn’s disease and psychiatric illness. Gastroenterology 87(2), 478–479 (1984).
   PubMed Web of Science ®Google Scholar
• North CS, Clouse RE, Spitznagel EL, Alpers DH. The relation of ulcerative colitis to psychiatric factors: a review of findings and methods. Am. J. Psychiatry 147(8), 974–981 (1990).
   PubMed Web of Science ®Google Scholar
• Drossman DA. Psychosocial factors in inflammatory bowel disease. In: Inflammatory Bowel Disease. Kirsner JB, Shorter RG (Eds). Williams & Wilkins, MD, USA (1995).
   Google Scholar
• Nahon S, Lahmek P, Durance C et al. Risk factors of anxiety and depression in inflammatory bowel disease. Inflamm. Bowel Dis. 18(11), 2086–2091 (2012).
   PubMed Web of Science ®Google Scholar
• McMahon AW, Schmitt P, Patterson JF, Rothman E. Personality differences between inflammatory bowel disease patients and their healthy siblings. Psychosom. Med. 35(2), 91–103 (1973).
   PubMed Web of Science ®Google Scholar
• Robertson DA, Ray J, Diamond I, Edwards JG. Personality profile and affective state of patients with inflammatory bowel disease. Gut 30(5), 623–626 (1989).
   PubMed Web of Science ®Google Scholar
• Gazzard BG, Price HL, Libby GW, Dawson AM. The social toll of Crohn’s disease. Br. Med. J. 2(6145), 1117–1119 (1978).
   PubMed Web of Science ®Google Scholar
• Barrett SM, Standen PJ, Lee AS, Hawkey CJ, Logan RF. Personality, smoking and inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 8(7), 651–655 (1996).
   PubMed Web of Science ®Google Scholar
• North CS, Alpers DH, Helzer JE, Spitznagel EL, Clouse RE. Do life events or depression exacerbate inflammatory bowel disease? A prospective study. Ann. Intern. Med. 114(5), 381–386 (1991).
   PubMed Web of Science ®Google Scholar
• Kurina LM, Goldacre MJ, Yeates D, Gill LE. Depression and anxiety in people with inflammatory bowel disease. J. Epidemiol. Community Health 55(10), 716–720 (2001).
   PubMed Web of Science ®Google Scholar
• Bennebroek Evertsz’ F, Thijssens NA, Stokkers PC et al. Do inflammatory bowel disease patients with anxiety and depressive symptoms receive the care they need? J. Crohns. Colitis 6(1), 68–76 (2012).
   PubMed Web of Science ®Google Scholar
• Häuser W, Janke KH, Klump B, Hinz A. Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm. Bowel Dis. 17(2), 621–632 (2011).
   PubMed Web of Science ®Google Scholar
• Filipovic BR, Filipovic BF, Kerkez M, Milinic N, Randelovic T. Depression and anxiety levels in therapy-naive patients with inflammatory bowel disease and cancer of the colon. World J. Gastroenterol. 13(3), 438–443 (2007).
   PubMed Web of Science ®Google Scholar
• Sajadinejad MS, Asgari K, Molavi H, Kalantari M, Adibi P. Psychological issues in inflammatory bowel disease: an overview. Gastroenterol. Res. Pract. 2012, 106502 (2012).
   PubMed Web of Science ®Google Scholar
• Walker JR, Ediger JP, Graff LA et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am. J. Gastroenterol. 103(8), 1989–1997 (2008).
   PubMed Web of Science ®Google Scholar
• Kilroy S, Nolan E, Sarma KM. Quality of life and level of anxiety in youths with inflammatory bowel disease in Ireland. J. Pediatr. Gastroenterol. Nutr. 53(3), 275–279 (2011).
   PubMed Web of Science ®Google Scholar
• Loftus EV Jr, Guérin A, Yu AP et al. Increased risks of developing anxiety and depression in young patients with Crohn’s disease. Am. J. Gastroenterol. 106(9), 1670–1677 (2011).
   PubMed Web of Science ®Google Scholar
• Burke P, Meyer V, Kocoshis S et al. Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis. J. Am. Acad. Child Adolesc. Psychiatry 28(6), 948–951 (1989).
   PubMed Web of Science ®Google Scholar
• Burke P, Meyer V, Kocoshis S, Orenstein D, Chandra R, Sauer J. Obsessive–compulsive symptoms in childhood inflammatory bowel disease and cystic fibrosis. J. Am. Acad. Child Adolesc. Psychiatry 28(4), 525–527 (1989).
   PubMed Web of Science ®Google Scholar
• Engström I. Mental health and psychological functioning in children and adolescents with inflammatory bowel disease: a comparison with children having other chronic illnesses and with healthy children. J. Child Psychol. Psychiatry. 33(3), 563–582 (1992).
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Singh S, Graff LA, Walker JR, Miller N, Cheang M. A prospective population-based study of triggers of symptomatic flares in IBD. Am. J. Gastroenterol. 105(9), 1994–2002 (2010).
   PubMed Web of Science ®Google Scholar
• Arapakis G, Lyketsos CG, Gerolymatos K, Richardson SC, Lyketsos GC. Low dominance and high intropunitiveness in ulcerative colitis and irritable bowel syndrome. Psychother. Psychosom. 46(4), 171–176 (1986).
   PubMed Web of Science ®Google Scholar
• Goldberg D. A psychiatric study of patients with diseases of the small intestine. Gut 11(6), 459–465 (1970).
   PubMed Web of Science ®Google Scholar
• Magni G, Bernasconi G, Mauro P et al. Psychiatric diagnoses in ulcerative colitis. A controlled study. Br. J. Psychiatry 158, 413–415 (1991).
   PubMed Web of Science ®Google Scholar
• Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut 28(12), 1600–1604 (1987).
   PubMed Web of Science ®Google Scholar
• Tarter RE, Switala J, Carra J, Edwards KL, Van Thiel DH. Inflammatory bowel disease: psychiatric status of patients before and after disease onset. Int. J. Psychiatry Med. 17(2), 173–181 (1987).
   PubMed Web of Science ®Google Scholar
• Walker EA, Gelfand MD, Gelfand AN, Creed F, Katon WJ. The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease. Gen. Hosp. Psychiatry 18(4), 220–229 (1996).
   PubMed Web of Science ®Google Scholar
• Mittermaier C, Dejaco C, Waldhoer T et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom. Med. 66(1), 79–84 (2004).
   PubMed Web of Science ®Google Scholar
• Guthrie E, Jackson J, Shaffer J, Thompson D, Tomenson B, Creed F. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn’s disease. Am. J. Gastroenterol. 97(8), 1994–1999 (2002).
   PubMed Web of Science ®Google Scholar
• Creed FH, Ratcliffe J, Fernandes L et al. Depressive, panic and neurasthenic disorders predict poor outcome in severe irritable bowel syndrome unless suitably treated. Br. J. Psychiatry 186, 507–515 (2005).
   PubMed Web of Science ®Google Scholar
• Simrén M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am. J. Gastroenterol. 97(2), 389–396 (2002).
   PubMed Web of Science ®Google Scholar
• Moradkhani A, Beckman LJ, Tabibian JH. Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors. J. Crohns. Colitis (2012).
   PubMedGoogle Scholar
• Hyphantis TN, Tomenson B, Bai M, Tsianos E, Mavreas V, Creed F. Psychological distress, somatization, and defense mechanisms associated with quality of life in inflammatory bowel disease patients. Dig. Dis. Sci. 55(3), 724–732 (2010).
   PubMed Web of Science ®Google Scholar
• Raja SN, Williams S, McGee R. Multidimensional health locus of control beliefs and psychological health for a sample of mothers. Soc. Sci. Med. 39(2), 213–220 (1994).
   PubMed Web of Science ®Google Scholar
• Ondersma SJ, Lumley MA, Corlis ME, Tojek TM, Tolia V. Adolescents with inflammatory bowel disease: the roles of negative affectivity and hostility in subjective versus objective health. J. Pediatr. Psychol. 22(5), 723–738 (1997).
   PubMed Web of Science ®Google Scholar
• Bond M. An empirical study of defense styles: the defense style questionnaire. In: Ego Mechanisms of Defense: a Guide for Clinicians and Researchers. Vaillant GE (Ed.). American Psychiatric Press, Washington, DC, USA (1992).
   Google Scholar
• Hyphantis TN, Triantafillidis JK, Pappa S et al. Defense mechanisms in inflammatory bowel disease. J. Gastroenterol. 40(1), 24–30 (2005).
   PubMed Web of Science ®Google Scholar
• Leibig T, Wilke E, Feiereis H. Personality structure of patients with ulcerative colitis and Crohn disease, a psychological test study in disease remission. Z. Psychosom. Med. Psychoanal. 31(4), 380–392 (1985).
   PubMedGoogle Scholar
• Tocchi A, Lepre L, Liotta G et al. Familial and psychological risk factors of ulcerative colitis. Ital. J. Gastroenterol. Hepatol. 29(5), 395–398 (1997).
   PubMedGoogle Scholar
• Addolorato G, Capristo E, Stefanini GF, Gasbarrini G. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand. J. Gastroenterol. 32(10), 1013–1021 (1997).
   PubMed Web of Science ®Google Scholar
• Boye B, Jahnsen J, Mokleby K et al. The INSPIRE study: are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn’s disease? Inflamm. Bowel Dis. 14(5), 680–686 (2008).
   PubMed Web of Science ®Google Scholar
• Ringel Y, Drossman DA. Psychosocial aspects of Crohn’s disease. Surg. Clin. North Am. 81(1), 231–252 (2001).
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm. Bowel Dis. 13(2), 225–234 (2007).
   PubMed Web of Science ®Google Scholar
• Goodhand JR, Wahed M, Rampton DS. Management of stress in inflammatory bowel disease: a therapeutic option? Expert Rev. Gastroenterol. Hepatol. 3(6), 661–679 (2009).
   PubMedGoogle Scholar
• Bitton A, Sewitch MJ, Peppercorn MA et al. Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am. J. Gastroenterol. 98(10), 2203–2208 (2003).
   PubMed Web of Science ®Google Scholar
• Riley SA, Mani V, Goodman MJ, Lucas S. Why do patients with ulcerative colitis relapse? Gut 31(2), 179–183 (1990).
   PubMed Web of Science ®Google Scholar
• Duffy LC, Zielezny MA, Marshall JR et al. Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav. Med. 17(3), 101–110 (1991).
   PubMed Web of Science ®Google Scholar
• Levenstein S, Prantera C, Varvo V et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am. J. Gastroenterol. 95(5), 1213–1220 (2000).
   PubMed Web of Science ®Google Scholar
• Mardini HE, Kip KE, Wilson JW. Crohn’s disease: a two-year prospective study of the association between psychological distress and disease activity. Dig. Dis. Sci. 49(3), 492–497 (2004).
   PubMed Web of Science ®Google Scholar
• Mittermaier C, Dejaco C, Waldhoer T et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom. Med. 66(1), 79–84 (2004).
   PubMed Web of Science ®Google Scholar
• Persoons P, Vermeire S, Demyttenaere K et al. The impact of major depressive disorder on the short- and long-term outcome of Crohn’s disease treatment with infliximab. Aliment. Pharmacol. Ther. 22(2), 101–110 (2005).
   PubMed Web of Science ®Google Scholar
• Vidal A, Gómez-Gil E, Sans M et al. Life events and inflammatory bowel disease relapse: a prospective study of patients enrolled in remission. Am. J. Gastroenterol. 101(4), 775–781 (2006).
   PubMed Web of Science ®Google Scholar
• Bitton A, Dobkin PL, Edwardes MD et al. Predicting relapse in Crohn’s disease: a biopsychosocial model. Gut 57(10), 1386–1392 (2008).
   PubMed Web of Science ®Google Scholar
• Deter HC, von Wietersheim J, Jantschek G, Burgdorf F, Blum B, Keller W; German Study Group on Psychosocial Intervention in Crohn’s Disease. High-utilizing Crohn’s disease patients under psychosomatic therapy. Biopsychosoc. Med. 2, 18 (2008).
   PubMedGoogle Scholar
• Levenstein S, Prantera C, Varvo V et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am. J. Gastroenterol. 89(8), 1219–1225 (1994).
   PubMed Web of Science ®Google Scholar
• Maunder RG, Greenberg GR, Hunter JJ, Lancee WJ, Steinhart AH, Silverberg MS. Psychobiological subtypes of ulcerative colitis: pANCA status moderates the relationship between disease activity and psychological distress. Am. J. Gastroenterol. 101(11), 2546–2551 (2006).
   PubMed Web of Science ®Google Scholar
• von Wietersheim J, Köhler T, Feiereis H. Relapse-precipitating life events and feelings in patients with inflammatory bowel disease. Psychother. Psychosom. 58(2), 103–112 (1992).
   PubMed Web of Science ®Google Scholar
• Nahon S, Lahmek P, Saas C et al. Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey. Inflamm. Bowel Dis. 17(6), 1270–1276 (2011).
   PubMed Web of Science ®Google Scholar
• Lerebours E, Gower-Rousseau C, Merle V et al. Stressful life events as a risk factor for inflammatory bowel disease onset: a population-based case–control study. Am. J. Gastroenterol. 102(1), 122–131 (2007).
   PubMed Web of Science ®Google Scholar
• Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm. Bowel Dis. 12(8), 697–707 (2006).
   PubMed Web of Science ®Google Scholar
• Triantafillidis JK, Hyphantis T, Cheracakis P, Antoniou A, Sklavaina M. Suicide as an outcome in patients with inflammatory bowel disease. Am. J. Gastroenterol. 97(4), 1066–1068 (2002).
   PubMedGoogle Scholar
• Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm. Bowel Dis. 15(7), 1105–1118 (2009).
   PubMed Web of Science ®Google Scholar
• Cámara RJ, Ziegler R, Begré S, Schoepfer AM, von Känel R; Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS) group. The role of psychological stress in inflammatory bowel disease: quality assessment of methods of 18 prospective studies and suggestions for future research. Digestion 80(2), 129–139 (2009).
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Walker JR, Graff LA. On studying the connection between stress and IBD. Am. J. Gastroenterol. 101(4), 782–785 (2006).
   PubMed Web of Science ®Google Scholar
• Rampton D. Does stress influence inflammatory bowel disease? The clinical data. Dig. Dis. 27(Suppl. 1), 76–79 (2009).
   PubMed Web of Science ®Google Scholar
• Santos J, Alonso C, Vicario M, Ramos L, Lobo B, Malagelada JR. Neuropharmacology of stress-induced mucosal inflammation: implications for inflammatory bowel disease and irritable bowel syndrome. Curr. Mol. Med. 8(4), 258–273 (2008).
   PubMed Web of Science ®Google Scholar
• Gareau MG, Silva MA, Perdue MH. Pathophysiological mechanisms of stress-induced intestinal damage. Curr. Mol. Med. 8(4), 274–281 (2008).
   PubMed Web of Science ®Google Scholar
• Mackner LM, Clough-Paabo E, Pajer K, Lourie A, Crandall WV. Psychoneuroimmunologic factors in inflammatory bowel disease. Inflamm. Bowel Dis. 17(3), 849–857 (2011).
   PubMed Web of Science ®Google Scholar
• Konturek PC, Brzozowski T, Konturek SJ. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J. Physiol. Pharmacol. 62(6), 591–599 (2011).
   PubMed Web of Science ®Google Scholar
• Gareau MG, Silva MA, Perdue MH. Pathophysiological mechanisms of stress-induced intestinal damage. Curr. Mol. Med. 8(4), 274–281 (2008).
   PubMed Web of Science ®Google Scholar
• Caso JR, Leza JC, Menchén L. The effects of physical and psychological stress on the gastro-intestinal tract: lessons from animal models. Curr. Mol. Med. 8(4), 299–312 (2008).
   PubMed Web of Science ®Google Scholar
• Snoek SA, Verstege MI, Boeckxstaens GE, van den Wijngaard RM, de Jonge WJ. The enteric nervous system as a regulator of intestinal epithelial barrier function in health and disease. Expert Rev. Gastroenterol. Hepatol. 4(5), 637–651 (2010).
   PubMed Web of Science ®Google Scholar
• Taché Y, Bernstein CN. Evidence for the role of the brain-gut axis in inflammatory bowel disease: depression as cause and effect? Gastroenterology 136(7), 2058–2061 (2009).
   PubMed Web of Science ®Google Scholar
• Larauche M, Kiank C, Tache Y. Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications. J. Physiol. Pharmacol. 60(Suppl. 7), 33–46 (2009).
   PubMedGoogle Scholar
• Taché Y. Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology? Gut 53(7), 919–921 (2004).
   PubMed Web of Science ®Google Scholar
• Mawdsley JE, Macey MG, Feakins RM, Langmead L, Rampton DS. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology 131(2), 410–419 (2006).
   PubMed Web of Science ®Google Scholar
• Kuroki T, Ohta A, Sherriff-Tadano R et al. Imbalance in the stress-adaptation system in patients with inflammatory bowel disease. Biol. Res. Nurs. 13(4), 391–398 (2011).
   PubMed Web of Science ®Google Scholar
• Matsunaga H, Hokari R, Ueda T et al. Physiological stress exacerbates murine colitis by enhancing proinflammatory cytokine expression that is dependent on IL-18. Am. J. Physiol. Gastrointest. Liver Physiol. 301(3), G555–G564 (2011).
   Google Scholar
• Wahed M, Corser M, Goodhand JR, Rampton DS. Does psychological counseling alter the natural history of inflammatory bowel disease? Inflamm. Bowel Dis. 16(4), 664–669 (2010).
   PubMed Web of Science ®Google Scholar
• von Wietersheim J, Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm. Bowel Dis. 12(12), 1175–1184 (2006).
   PubMed Web of Science ®Google Scholar
• Deter HC, Keller W, von Wietersheim J, Jantschek G, Duchmann R, Zeitz M; German Study Group on Psychosocial Intervention in Crohn’s Disease. Psychological treatment may reduce the need for healthcare in patients with Crohn’s disease. Inflamm. Bowel Dis. 13(6), 745–752 (2007).
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Antidepressants and inflammatory bowel disease: a systematic review. Clin. Pract. Epidemiol. Ment. Health 2, 24 (2006).
   PubMedGoogle Scholar
• Boye B, Lundin KE, Jantschek G et al. INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn’s disease? A randomized controlled trial. Inflamm. Bowel Dis. 17(9), 1863–1873 (2011).
   PubMed Web of Science ®Google Scholar
• Maunder RG, Levenstein S. The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence. Curr. Mol. Med. 8(4), 247–252 (2008).
   PubMed Web of Science ®Google Scholar
• Goodhand J, Rampton D. Psychological stress and coping in IBD. Gut 57(10), 1345–1347 (2008).
   PubMed Web of Science ®Google Scholar
• Timmer A, Preiss JC, Motschall E, Rücker G, Jantschek G, Moser G. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst. Rev. 2, CD006913 (2011).
   Google Scholar
• Szigethy E, Whitton SW, Levy-Warren A, DeMaso DR, Weisz J, Beardslee WR. Cognitive-behavioral therapy for depression in adolescents with inflammatory bowel disease: a pilot study. J. Am. Acad. Child Adolesc. Psychiatry 43(12), 1469–1477 (2004).
   PubMed Web of Science ®Google Scholar
• Szigethy E, Kenney E, Carpenter J et al. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J. Am. Acad. Child Adolesc. Psychiatry 46(10), 1290–1298 (2007).
   PubMed Web of Science ®Google Scholar
• Keefer L, Doerfler B, Artz C. Optimizing management of Crohn’s disease within a project management framework: results of a pilot study. Inflamm. Bowel Dis. 18(2), 254–260 (2012).
   PubMed Web of Science ®Google Scholar
• Mawdsley JE, Jenkins DG, Macey MG, Langmead L, Rampton DS. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am. J. Gastroenterol. 103(6), 1460–1469 (2008).
   PubMed Web of Science ®Google Scholar
• Keefer L, Keshavarzian A. Feasibility and acceptability of gut-directed hypnosis on inflammatory bowel disease: a brief communication. Int. J. Clin. Exp. Hypn. 55(4), 457–466 (2007).
   PubMed Web of Science ®Google Scholar
• Keefer L, Kiebles JL, Martinovich Z, Cohen E, Van Denburg A, Barrett TA. Behavioral interventions may prolong remission in patients with inflammatory bowel disease. Behav. Res. Ther. 49(3), 145–150 (2011).
   PubMed Web of Science ®Google Scholar
• Keefer L, Kiebles JL, Kwiatek MA et al. The potential role of a self-management intervention for ulcerative colitis: a brief report from the ulcerative colitis hypnotherapy trial. Biol. Res. Nurs. 14(1), 71–77 (2012).
   PubMed Web of Science ®Google Scholar
• Taft TH, Keefer L, Leonhard C, Nealon-Woods M. Impact of perceived stigma on inflammatory bowel disease patient outcomes. Inflamm. Bowel Dis. 15(8), 1224–1232 (2009).
   PubMed Web of Science ®Google Scholar
• Keefer L, Kiebles JL, Taft TH. The role of self-efficacy in inflammatory bowel disease management: preliminary validation of a disease-specific measure. Inflamm. Bowel. Dis. 17, 614–620 (2011).
   Google Scholar
• Kiebles JL, Doerfler B, Keefer L. Preliminary evidence supporting a framework of psychological adjustment to inflammatory bowel disease. Inflamm. Bowel Dis. 16(10), 1685–1695 (2010).
   PubMed Web of Science ®Google Scholar
• Levy RL, Langer SL, Whitehead WE. Social learning contributions to the etiology and treatment of functional abdominal pain and inflammatory bowel disease in children and adults. World J. Gastroenterol. 13(17), 2397–2403 (2007).
   PubMed Web of Science ®Google Scholar
• Hoes JN, Jacobs JW, Verstappen SM, Bijlsma JW, Van der Heijden GJ. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis. Ann. Rheum. Dis. 68(12), 1833–1838 (2009).
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus AA, Gordon AL, Stewart BJ, Andrews JM. The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case-note audit. J. Psychosom. Res. 72(2), 165–167 (2012).
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus AA, Gordon AL, Stewart BJ, Andrews JM. A magic pill? A qualitative analysis of patients’ views on the role of antidepressant therapy in inflammatory bowel disease (IBD). BMC Gastroenterol. 12, 93 (2012).
   PubMedGoogle Scholar
• Esposito G, Filippis DD, Cirillo C et al. Cannabidiol in inflammatory bowel diseases: a brief overview. Phytother. Res. doi:10.1002/ptr.4781 (2012) (Epub ahead of print).
   PubMedGoogle Scholar
• Daneshmand A, Mohammadi H, Rahimian R et al. Chronic lithium administration ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats; potential role for adenosine triphosphate sensitive potassium channels. J. Gastroenterol. Hepatol. 26(7), 1174–1181 (2011).
   PubMed Web of Science ®Google Scholar
• Goodhand JR, Greig FI, Koodun Y et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study. Inflamm. Bowel Dis. 18(7), 1232–1239 (2011).
   Web of Science ®Google Scholar
• Tang Y, Preuss F, Turek FW, Jakate S, Keshavarzian A. Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis. Sleep Med. 10(6), 597–603 (2009).
   PubMed Web of Science ®Google Scholar
• Keefer L, Stepanski EJ, Ranjbaran Z, Benson LM, Keshavarzian A. An initial report of sleep disturbance in inactive inflammatory bowel disease. J. Clin. Sleep Med. 2(4), 409–416 (2006).
   PubMed Web of Science ®Google Scholar
• Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J. Gastroenterol. Hepatol. 22(11), 1748–1753 (2007).
   PubMed Web of Science ®Google Scholar
• Swanson GR, Burgess HJ, Keshavarzian A. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare? Expert Rev. Clin. Immunol. 7(1), 29–36 (2011).
   PubMed Web of Science ®Google Scholar
• Singh S, Blanchard A, Walker JR, Graff LA, Miller N, Bernstein CN. Common symptoms and stressors among individuals with inflammatory bowel diseases. Clin. Gastroenterol. Hepatol. 9(9), 769–775 (2011).
   PubMed Web of Science ®Google Scholar
• Makharia GK. Understanding and treating abdominal pain and spasms in organic gastrointestinal diseases: inflammatory bowel disease and biliary diseases. J. Clin. Gastroenterol. 45(Suppl.), S89–S93 (2011).
   Google Scholar
• Long MD, Drossman DA. Inflammatory bowel disease, irritable bowel syndrome, or what?: A challenge to the functional-organic dichotomy. Am. J. Gastroenterol. 105(8), 1796–1798 (2010).
   PubMed Web of Science ®Google Scholar
• Bielefeldt K, Davis B, Binion DG. Pain and inflammatory bowel disease. Inflamm. Bowel Dis. 15(5), 778–788 (2009).
   PubMed Web of Science ®Google Scholar
• Goodhand JR, Wahed M, Mawdsley JE, Farmer AD, Aziz Q, Rampton DS. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm. Bowel Dis. 18(12), 2301–2309 (2012).
   PubMed Web of Science ®Google Scholar